Insider Transactions in Q4 2024 at Guardant Health, Inc. (GH)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 15
2024
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.51%
|
-
|
Oct 15
2024
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+5.0%
|
-
|
Oct 04
2024
|
Meghan V. Joyce Director |
BUY
Exercise of conversion of derivative security
|
Direct |
66
+0.63%
|
-
|
Oct 01
2024
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,824
-10.4%
|
$84,128
$22.12 P/Share
|
Oct 01
2024
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,543
+9.14%
|
-
|
Oct 01
2024
|
Darya Chudova Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,009
-7.45%
|
$88,198
$22.12 P/Share
|
Oct 01
2024
|
Darya Chudova Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,908
+6.82%
|
-
|
Oct 01
2024
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,200
-15.29%
|
$92,400
$22.12 P/Share
|
Oct 01
2024
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,284
+13.44%
|
-
|
Oct 01
2024
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,620
-10.32%
|
$79,640
$22.12 P/Share
|
Oct 01
2024
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,498
+11.06%
|
-
|
Oct 01
2024
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,980
-10.75%
|
$65,560
$22.12 P/Share
|
Oct 01
2024
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,877
+9.88%
|
-
|
Oct 01
2024
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,162
-14.74%
|
$91,564
$22.12 P/Share
|
Oct 01
2024
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,211
+22.53%
|
-
|